Oncology CRO Email us info@sms-oncology.com
Follow us on

The 4D oncology CRO

Drug – Data – Dossier

The path to successful development of oncology drugs is geared by generation of clinical data that builds up a compliant regulatory dossier. Oncology drug development is complex and direction is required to navigate a safe passageway by avoiding risks and leveraging opportunities to increase the chances of success.


SMS-oncology adds an extra dimension to clinical cancer research by providing direction to our sponsors. During the study we turn complex data into meaningful insights using our oncology expertise. This information helps our sponsors to make informed decisions, stay in control, mitigate risks, identify opportunities and collect the right data to build the regulatory dossier. SMS-oncology: an oncology CRO adding value by providing direction.

Our oncology services

Clinical operations Read more

Clinical operations

From initiation and implementation to completion of oncology clinical trials with a specialization in:
• Early phase oncology trials
• Immuno-oncology trials

Consultancy Read more


From strategic expert advice on oncology drug development and trial design to protocol writing and scientific advisory boards.

4D service Read more

4D service

From upfront strategic advice translated into clinical operations to frequent meaningful insights during study conduct.

Our advantages

Responsiveness, Quality & Flexibility
  • Responsive and "right-sized" project teams for close collaboration, flexibility and fast-decision making
  • Close and personal involvement of the management team ensuring a high standard of quality
  • Delivering tailor made solutions by offering full or functional services as needed
Oncology Experts
  • In-depth knowledge of the complex nature of early phase oncology and immuno-oncology studies
  • Dedicated professionals with oncology know-how and experience in all functions of the company
  • Extensive network of Key Opinion Leaders throughout Europe
  • Proactively addressing challenges before they turn into hurdles
  • Strategic clinical development advice that can be directly translated into clinical operations
  • Turning complex data into meaningful insights during study conduct using our oncology expertise


6 May 2016

Our latest newsletter Oncology Highlights April 2016 is online!

21 April 2016

SMS-oncology takes part in the international 'PRECIOUS' consortium.

16-20 April 2016

Our colleagues Raymond Hoffmans (CBDO) and Nadina Grosios (Director Consultancy) are attending the AACR Annual Meeting in New Orleans, US.

Conference schedule

10-12 May 2016

CIMT Annual Meeting, Mainz, Germany

26 May 2016

Knowledge for Growth, Ghent, Belgium

Recent blog posts